192 related articles for article (PubMed ID: 19918687)
1. Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication.
Batista CA; Silva FM; Barbuti RC; Eisig JN; Mattar R; Navarro-Rodriguez T
Arq Gastroenterol; 2009; 46(3):204-8. PubMed ID: 19918687
[TBL] [Abstract][Full Text] [Related]
2. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
3. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L
Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617
[TBL] [Abstract][Full Text] [Related]
4. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Yamamoto K
J Gastroenterol Hepatol; 2009 Jan; 24(1):107-13. PubMed ID: 18823429
[TBL] [Abstract][Full Text] [Related]
6. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease.
Lai CH; Poon SK; Chen YC; Chang CS; Wang WC
Helicobacter; 2005 Dec; 10(6):577-85. PubMed ID: 16302983
[TBL] [Abstract][Full Text] [Related]
7. Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.
Lehmann FS; Drewe J; Terracciano L; Beglinger C
Aliment Pharmacol Ther; 2000 Mar; 14(3):305-9. PubMed ID: 10735923
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
[TBL] [Abstract][Full Text] [Related]
9. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Mabe K; Takahashi M; Oizumi H; Tsukuma H; Shibata A; Fukase K; Matsuda T; Takeda H; Kawata S
World J Gastroenterol; 2009 Sep; 15(34):4290-7. PubMed ID: 19750572
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Pilotto A; Perri F; Leandro G; Franceschi M;
Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
[TBL] [Abstract][Full Text] [Related]
11. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
Kawabata H; Habu Y; Tomioka H; Kutsumi H; Kobayashi M; Oyasu K; Hayakumo T; Mizuno S; Kiyota K; Nakajima M; Kimoto K; Inokuchi H; Kawai K
Aliment Pharmacol Ther; 2003 Jan; 17(2):259-64. PubMed ID: 12534411
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
13. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
14. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
16. The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
Güliter S; Kandilci U
J Clin Gastroenterol; 2004 Oct; 38(9):750-5. PubMed ID: 15365399
[TBL] [Abstract][Full Text] [Related]
17. Association of erosive esophagitis with Helicobacter pylori eradication: a role of salivary bicarbonate and glycoprotein secretion.
Namiot DB; Namiot Z; Markowski AR; Leszczyńska K; Bucki R; Kemona A; Gołebiewska M
Dis Esophagus; 2009; 22(4):368-73. PubMed ID: 19222537
[TBL] [Abstract][Full Text] [Related]
18. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.
Mattar R; dos Santos AF; Eisig JN; Rodrigues TN; Silva FM; Lupinacci RM; Iriya K; Carrilho FJ
Helicobacter; 2005 Dec; 10(6):601-8. PubMed ID: 16302986
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
20. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
